Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery s…
Medical - Specialties
US, New York [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Delcath Systems, Inc. has no acquisition track records yet.
M&A Deals · History
Delcath Systems, Inc. has no acquisition track records yet.